Anti-anxiety recalled due to 'foreign substance' and infection risk

Mylan Pharmaceuticals Inc. recalls much of the antispasmodic drug alprazolam – often sold under the brand name Xanax – "due to the potential presence of a foreign substance," the company said last week.

Mylan Pharmaceuticals Inc. is recalling a number of antipon drugs alprazolam – usually sold under the brand name Xanax – "because of the potential presence of a foreign drug," the company said last week.

The company said the probability of someone getting sick. "Expected to be rare, but the remote risk of infection in a patient cannot be ruled out." Mylan added that as of Friday's announcement, there had been no reports of adverse events related to the party in question. [19659004] M ylan refused to provide any further information about the product or foreign drug.

The voluntary recall includes a single batch of bottles, each containing 500 0.5-milligram tablets, distributed in the United States between July and August. The number affected was 8082708, and the expiry date is listed as September 2020.

Instructions for wholesalers, retailers and consumers to return recalled bottles can be found in the company's announcement, which was also posted to the US Food and Drug Agency's website. Adverse events can be reported to the agency's MedWatch program for reporting adverse events.

By Michael Nedelman, CNN

Trademark and Copyright 2019 Cable News Network, Inc., a Time Warner Company. All rights reserved.

Source link

Back to top button